Sunday, November 29, 2009

Health Canada Approves New Treatment Option For Canadians At High Risk Of Heart Attack Or Stroke

MICARDIS® (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.

The details can be read here.

No comments: